{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:03:38Z","timestamp":1783127018736,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010749","name":"Comiss\u00e3o Nacional de Energia Nuclear","doi-asserted-by":"publisher","award":["01341.011064\/2021-71"],"award-info":[{"award-number":["01341.011064\/2021-71"]}],"id":[{"id":"10.13039\/501100010749","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/010.000981\/2019"],"award-info":[{"award-number":["E-26\/010.000981\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/200.815\/2021"],"award-info":[{"award-number":["E-26\/200.815\/2021"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["301069\/2018-2"],"award-info":[{"award-number":["301069\/2018-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jpba.2022.115024","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T21:37:38Z","timestamp":1661809058000},"page":"115024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploiting the extemporaneousness of radiopharmaceuticals: Radiolabeling stability under diverse conditions"],"prefix":"10.1016","volume":"221","author":[{"given":"Andr\u00e9","family":"Damasceno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha Sahyl\u00ed Ortega","family":"Pijeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ricci-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Magalh\u00e3es Rebelo","family":"Alencar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"\u0130lem-\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Santos-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2022.115024_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.630827","article-title":"Radiopharmaceutical Validation for Clinical Use","volume":"11","author":"Kunos","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpba.2022.115024_bib2","series-title":"Basic Sci. Nucl. Med.","article-title":"Quality assurance and quality control of Tc-99m radiopharmaceuticals","author":"Loveless","year":"2021"},{"key":"10.1016\/j.jpba.2022.115024_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s12350-017-1131-5","article-title":"Radiopharmaceutical tracers for cardiac imaging","volume":"25","author":"Manabe","year":"2018","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jpba.2022.115024_bib4","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2967\/jnumed.118.208603","article-title":"Modern radiopharmaceutical dosimetry should include robust biodistribution reporting","volume":"59","author":"Kesner","year":"2018","journal-title":"J. Nucl. Med"},{"key":"10.1016\/j.jpba.2022.115024_bib5","first-page":"306","article-title":"Theragnostic radionuclides: a clinical perspective, QJ","volume":"65","author":"Koziorowski","year":"2021","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jpba.2022.115024_bib6","first-page":"49","article-title":"Quality control on radiochemical purity in Technetium-99m radiopharmaceuticals labelling: three years of experience on 2280 procedures","volume":"88","author":"Maioli","year":"2017","journal-title":"Acta Bio Med. Atenei Parm."},{"key":"10.1016\/j.jpba.2022.115024_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/MNM.0b013e3283488ce8","article-title":"Radiochemical purity testing of 99mTc-labelled radiopharmaceuticals: how much is enough?","volume":"32","author":"Ballinger","year":"2011","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.jpba.2022.115024_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00259-010-1407-3","article-title":"Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals","volume":"37","author":"Elsinga","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jpba.2022.115024_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41181-018-0052-1","article-title":"Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals","volume":"4","author":"de Blois","year":"2019","journal-title":"EJNMMI Radiopharm. Chem."},{"key":"10.1016\/j.jpba.2022.115024_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/pauz.200500149","article-title":"[Quality control of radiopharmaceuticals]","volume":"34","author":"Maier","year":"2005","journal-title":"Pharm. Unserer Zeit"},{"key":"10.1016\/j.jpba.2022.115024_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.4103\/ijnm.ijnm_222_20","article-title":"A comparative study of pharmacopoeial quality standards and regulations of radiopharmaceuticals, Indian J. Nucl. Med. IJNM Off","volume":"36","author":"Thota","year":"2021","journal-title":"J. Soc. Nucl. Med. India"},{"key":"10.1016\/j.jpba.2022.115024_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2967\/jnmt.107.044156","article-title":"Procedure guideline for the use of radiopharmaceuticals 4.0","volume":"35","author":"Callahan","year":"2007","journal-title":"J. Nucl. Med. Technol."},{"key":"10.1016\/j.jpba.2022.115024_bib13","first-page":"175","author":"Radiopharmaceuticals","year":"1991","journal-title":"Legis. basis: Dir. 65\/65\/EEC, 75\/318\/EEC Amend., Dir. 89\/343\/EEC"},{"key":"10.1016\/j.jpba.2022.115024_bib14","unstructured":"J.F. Castner, D.D. Zdankiewicz, J.E. Anderson, EP2419096A2 - Stabilization of radiopharmaceutical compositions using ascorbic acid, 2015. https:\/\/patents.google.com\/patent\/EP2419096A2\/en (accessed June 24, 2022)."},{"key":"10.1016\/j.jpba.2022.115024_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.semnuclmed.2019.07.001","article-title":"Design and challenges of radiopharmaceuticals","volume":"49","author":"Vermeulen","year":"2019","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.jpba.2022.115024_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.apradiso.2008.08.015","article-title":"Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography","volume":"67","author":"Scott","year":"2009","journal-title":"Appl. Radiat. Isot."},{"key":"10.1016\/j.jpba.2022.115024_bib17","unstructured":"SNM Committee on Pharmacopeia, SNM Commission on Radiopharmaceuticals, Recommendations for Beyond-Use Dates (BUD) for Tc-99m Radiopharmaceuticals, (n.d.) 1\u20134. https:\/\/s3.amazonaws.com\/rdcms-snmmi\/files\/production\/public\/docs\/BUDs_for_Tc99m_radiopharmaceuticals.pdf."},{"key":"10.1016\/j.jpba.2022.115024_bib18","first-page":"51","article-title":"Role of radioisotope 99m Tc and scintillation gamma camera in assessment of multiple renal functional indices using two different carriers DTPA & MDP, IOSR","volume":"6","author":"Elden","year":"2014","journal-title":"J. Appl. Phys."},{"key":"10.1016\/j.jpba.2022.115024_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12880-019-0345-1","article-title":"Accurate characterization of 99mTc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT\/CT","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Med. Imaging"},{"key":"10.1016\/j.jpba.2022.115024_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.nucmedbio.2014.11.010","article-title":"Detection of breast cancer microcalcification using 99mTc-MDP SPECT or Osteosense 750EX FMT imaging","volume":"42","author":"Felix","year":"2015","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jpba.2022.115024_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1053\/j.semnuclmed.2016.07.003","article-title":"18F-NaF-PET\/CT and 99mTc-MDP bone scintigraphy in the detection of bone metastases in prostate cancer","volume":"46","author":"Langsteger","year":"2016","journal-title":"Semin. Nucl. Med."},{"key":"10.1016\/j.jpba.2022.115024_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365513.2020.1759138","article-title":"Glomerular filtration rate: comparison of simultaneous plasma clearance of 99mTc-DTPA and 51Cr-EDTA revisited","volume":"80","author":"Simonsen","year":"2020","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.jpba.2022.115024_bib23","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00252388","article-title":"Clinical experience with 99mTc-MAG3, mercaptoacetyltriglycine, and a comparison with 99mTc-DTPA","volume":"14","author":"Al-Nahhas","year":"1988","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.jpba.2022.115024_bib24","first-page":"1","article-title":"Preparation and quality control of 99m Tc-MDP","author":"Bernardes","year":"2005","journal-title":"Int. Nucl. Atl. Conf. Ina., Assoc. Bras. De. Energ. Nucl. - ABEN, St., Braz."},{"key":"10.1016\/j.jpba.2022.115024_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/00365518809085779","article-title":"Stability, protein binding and clearance studies of [99mTc] DTPA. Evaluation of a commercially available dry-kit","volume":"48","author":"Rehling","year":"1988","journal-title":"Scand. J. Clin. Lab. Invest."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708522004459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T15:26:39Z","timestamp":1778513199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708522004459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":25,"alternative-id":["S0731708522004459"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115024","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploiting the extemporaneousness of radiopharmaceuticals: Radiolabeling stability under diverse conditions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2022.115024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115024"}}